ASTM F1862/F1862M-17

This document is not an ASTM standard and is intended only to provide the user of an ASTM standard an indication of what changes have been made to the previous version. Because
it may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current version
of the standard as published by ASTM is to be considered the official document.
Designation: F1862/F1862M − 13 F1862/F1862M − 17
Standard Test Method for
Resistance of Medical Face Masks to Penetration by
Synthetic Blood (Horizontal Projection of Fixed Volume at a
1
Known Velocity)
This standard is issued under the fixed designation F1862/F1862M; the number immediately following the designation indicates the year
of original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval.
A superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
INTRODUCTION
Workers, primarily those in the health care healthcare profession, involved in treating and caring for
individuals injured or sick, can be exposed to biological liquids capable of transmitting disease. These
diseases, which may be caused by a variety of microorganisms, can pose significant risks to life and
health. This is especially true of blood-borne viruses which cause Hepatitis (Hepatitishepatitis
(hepatitis B Virusvirus (HBV) and Hepatitishepatitis C Virusvirus (HCV)) and Acquired Immune
Deficiency Syndrome (AIDS) [Human Immunodeficiency Virus (HIV)].acquired immune deficiency
syndrome (AIDS) (human immunodeficiency virus (HIV)). Because engineering controls can not
eliminate all possible exposures, attention is placed on reducing the potential of direct skin and
mucous membrane contact through the use of protective clothing that resists penetration (29 CFR Part
1910.1030). This test method was developed for ranking the synthetic blood penetration resistance
performance of medical ace masks in a manner representing actual use as might occur when the face
mask is contacted by a high velocity high-velocity stream of blood from a punctured wound.
1. Scope
1.1 This test method is used to evaluate the resistance of medical face masks to penetration by the impact of a small volume
(~2 mL) of a high velocity high-velocity stream of synthetic blood. Medical face mask pass/fail determinations are based on visual
detection of synthetic blood penetration.
1.2 This test method does not apply to all forms or conditions of blood-borne pathogen exposure. Users of the test method must
review modes for face exposure and assess the appropriateness of this test method for their specific application.
1.3 This test method primarily addresses the performance of materials or certain material constructions used in medical face
masks. This test method does not address the performance of the medical face mask’s design, construction, or interfaces or other
factors with the potential to affect the overall protection offered by the medical face mask and its operation (such as filtration
efficiency and pressure drop). Procedures for measuring these properties are contained in Test MethodsMethod F2101 and
MIL-M-36954C.
1.4 This test method does not address breathability of the medical face mask materials or any other properties affecting the ease
of breathing through the medical face mask. This test method evaluates medical face masks as an item of protective clothing. This
test method does not evaluate the performance of medical face masks for airborne exposure pathways or in the prevention of the
penetration of aerosolized body fluids deposited on the medical face mask.
1.5 The values stated in SI units or inch-pound units are to be regarded separately as standard. The pressure values stated in
each system are not exact equivalents. However, as the corresponding velocities are within 1 % of each other, (see X1.4.2),
reporting of the results in either units is permitted.
1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility
of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory
limitations prior to use.
1
This test method is under the jurisdiction of ASTM Committee F23 on Personal Protective Clothing and Equipment and is the direct responsibility of Subcommittee
F23.40 on Biological.
Current edition approved Dec. 1, 2013June 1, 2017. Published December 2013June 2017. Originally approved in 1998. Last previous edition approved in 20072013 as
F1862 - 07.F1862/F1862M – 13. DOI: 10.1520/F1862_F1862M-13.10.1520/F1862_F1862M-17.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
F1862/F1862M − 17
1.7 This international standard was developed in accordance with interna
...

NOTICE: This standard has either been superseded and replaced by a new version or withdrawn.
Contact ASTM International (www.astm.org) for the latest information
Designation: F1862/F1862M − 17
Standard Test Method for
Resistance of Medical Face Masks to Penetration by
Synthetic Blood (Horizontal Projection of Fixed Volume at a
1
Known Velocity)
This standard is issued under the fixed designation F1862/F1862M; the number immediately following the designation indicates the year
of original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval.
A superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
INTRODUCTION
Workers, primarily those in the healthcare profession, involved in treating and caring for individuals
injured or sick, can be exposed to biological liquids capable of transmitting disease. These diseases,
which may be caused by a variety of microorganisms, can pose significant risks to life and health. This
is especially true of blood-borne viruses which cause hepatitis (hepatitis B virus (HBV) and hepatitis
C virus (HCV)) and acquired immune deficiency syndrome (AIDS) (human immunodeficiency virus
(HIV)). Because engineering controls can not eliminate all possible exposures, attention is placed on
reducing the potential of direct skin and mucous membrane contact through the use of protective
clothing that resists penetration (29 CFR Part 1910.1030). This test method was developed for ranking
the synthetic blood penetration resistance performance of medical ace masks in a manner representing
actual use as might occur when the face mask is contacted by a high-velocity stream of blood from
a punctured wound.
1. Scope filtration efficiency and pressure drop). Procedures for measur-
ing these properties are contained in Test Method F2101 and
1.1 This test method is used to evaluate the resistance of
MIL-M-36954C.
medical face masks to penetration by the impact of a small
volume (~2 mL) of a high-velocity stream of synthetic blood.
1.4 This test method does not address breathability of the
Medical face mask pass/fail determinations are based on visual
medical face mask materials or any other properties affecting
detection of synthetic blood penetration.
the ease of breathing through the medical face mask. This test
method evaluates medical face masks as an item of protective
1.2 This test method does not apply to all forms or condi-
clothing. This test method does not evaluate the performance
tions of blood-borne pathogen exposure. Users of the test
of medical face masks for airborne exposure pathways or in the
method must review modes for face exposure and assess the
prevention of the penetration of aerosolized body fluids depos-
appropriateness of this test method for their specific applica-
ited on the medical face mask.
tion.
1.5 The values stated in SI units or inch-pound units are to
1.3 This test method primarily addresses the performance of
be regarded separately as standard. The pressure values stated
materials or certain material constructions used in medical face
in each system are not exact equivalents. However, as the
masks. This test method does not address the performance of
corresponding velocities are within 1 % of each other, (see
the medical face mask’s design, construction, or interfaces or
X1.4.2), reporting of the results in either units is permitted.
other factors with the potential to affect the overall protection
offered by the medical face mask and its operation (such as
1.6 This standard does not purport to address all of the
safety concerns, if any, associated with its use. It is the
responsibility of the user of this standard to establish appro-
1 priate safety and health practices and determine the applica-
This test method is under the jurisdiction of ASTM Committee F23 on Personal
Protective Clothing and Equipment and is the direct responsibility of Subcommittee
bility of regulatory limitations prior to use.
F23.40 on Biological.
1.7 This international standard was developed in accor-
Current edition approved June 1, 2017. Published June 2017. Originally
dance with internationally recognized principles on standard-
approved in 1998. Last previous edition approved in 2013 as F1862/F1862M – 13.
DOI: 10.1520/F1862_F1862M-17. ization established in the Decision on Principles for the
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
F1862/F1862M − 17
Development of International Standards, Guides and Recom- 3.1.4 body fluid, n—any liquid produced, secreted, or ex-
mendations issued by the World Trade Organization Technical creted by the human body.
Barriers to Trade (TBT) Committee. 3.1.4.1 Discussion—In this test method, body fluids include
liquids potentially infected with blood-borne pathogens,
2. Referenced Documents
including, but not limit
...